Description

n-[(2E)-3-Cyano-1-(3-Methoxypropyl)-10-Methyl-5-Oxo-1,5-Dihydro-2H-Dipyrido[1,2-A:2',3'-D]Pyrimidin-2-Ylidene]Acetamide is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of novel therapeutic agents. It is primarily sought after by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing innovative drug candidates.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel active pharmaceutical ingredients (APIs) targeting various disease pathways.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new drug discovery programs.
• Preclinical Development: Serves as a critical material for producing batches of candidate compounds for pharmacological and toxicological evaluation.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and scale-up of complex molecules for clients.
• Academic Research: Utilized in university and institutional labs for studying heterocyclic chemistry and developing new synthetic methodologies.

Basic Information

Product Name	n-[(2E)-3-Cyano-1-(3-Methoxypropyl)-10-Methyl-5-Oxo-1,5-Dihydro-2H-Dipyrido[1,2-A:2',3'-D]Pyrimidin-2-Ylidene]Acetamide
CAS No.	842955-93-5
Molecular Formula	C19H17N5O3
Molecular Weight	363.37 g/mol
Synonyms	Acetamide, N-[(2E)-3-cyano-1-(3-methoxypropyl)-10-methyl-5-oxo-1,5-dihydro-2H-dipyrido[1,2-a:2',3'-d]pyrimidin-2-ylidene]-; (2E)-2-(Acetylimino)-3-cyano-1-(3-methoxypropyl)-10-methyl-1,5-dihydro-2H-dipyrido[1,2-a:2',3'-d]pyrimidin-5-one; CAS 842955-93-5; 1,5-Dihydro-2H-dipyrido[1,2-a:2',3'-d]pyrimidin-2-ylideneacetamide derivative
EINECS	Contact for details

Quality Control

Our n-[(2E)-3-Cyano-1-(3-Methoxypropyl)-10-Methyl-5-Oxo-1,5-Dihydro-2H-Dipyrido[1,2-A:2',3'-D]Pyrimidin-2-Ylidene]Acetamide is manufactured under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements for pharmaceutical R&D. A detailed Certificate of Analysis (COA) is provided with each shipment, documenting key specifications such as assay purity and impurity profiles.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The container should be kept tightly sealed in a dry environment to minimize exposure to moisture. For long-term storage, consider inert gas purging.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0% Any single unknown impurity ≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.